1	Effect	Effect	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	U-995	U-995	B-NP	NN	B-cell_line	10	NMOD	0
4	,	,	O	,	O	10	P	0
5	a	a	B-NP	DT	O	10	NMOD	0
6	potent	potent	I-NP	JJ	O	10	NMOD	0
7	shark	shark	I-NP	NN	O	10	NMOD	0
8	cartilage-derived	cartilage-derived	I-NP	JJ	O	10	NMOD	0
9	angiogenesis	angiogenesis	I-NP	NN	O	10	NMOD	3	angiogenesis
10	inhibitor	inhibitor	I-NP	NN	O	2	PMOD	0
11	,	,	O	,	O	10	P	0
12	on	on	B-PP	IN	O	1	NMOD	0
13	anti-angiogenesis	anti-angiogenesis	B-NP	JJ	O	15	AMOD	3	angiogenesis
14	and	and	I-NP	CC	O	15	AMOD	0
15	anti-tumor	anti-tumor	I-NP	JJ	O	16	NMOD	0
16	activities	activity	I-NP	NNS	O	12	PMOD	18	activities
17	.	.	O	.	O	1	P	0

1	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	A	A	B-NP	DT	O	6	NMOD	0
4	potent	potent	I-NP	JJ	O	6	NMOD	0
5	angiogenesis	angiogenesis	I-NP	NN	O	6	NMOD	3	angiogenesis
6	inhibitor	inhibitor	I-NP	NN	O	8	NMOD	0
7	,	,	O	,	O	8	P	0
8	U-995	U-995	B-NP	NN	B-cell_line	10	SUB	0
9	,	,	O	,	O	8	P	0
10	has	have	B-VP	VBZ	O	1	NMOD	0
11	been	be	I-VP	VBN	O	10	VC	0
12	purified	purify	I-VP	VBN	O	11	VC	19	purified
13	from	from	B-PP	IN	O	12	VMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	cartilage	cartilage	I-NP	NN	O	13	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	the	the	B-NP	DT	O	19	NMOD	0
18	blue	blue	I-NP	JJ	O	19	NMOD	0
19	shark	shark	I-NP	NN	O	16	PMOD	0
20	(	(	O	(	O	23	DEP	0
21	Prionace	Prionace	B-NP	NN	O	22	NMOD	0
22	glauca	glauca	I-NP	NN	O	23	DEP	0
23	)	)	O	)	O	19	NMOD	0
24	.	.	O	.	O	10	P	0

1	U-995	U-995	B-NP	NN	B-cell_line	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	composed	compose	I-VP	VBN	O	2	VC	0
4	of	of	B-PP	IN	O	3	VMOD	0
5	two	two	B-NP	CD	O	7	NMOD	0
6	single	single	I-NP	JJ	O	7	NMOD	0
7	peptides	peptide	I-NP	NNS	O	4	PMOD	0
8	with	with	B-PP	IN	O	7	NMOD	0
9	molecular	molecular	B-NP	JJ	O	10	NMOD	0
10	mass	mass	I-NP	NN	O	8	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	10	10	B-NP	CD	O	14	AMOD	0
13	and	and	I-NP	CC	O	14	AMOD	0
14	14	14	I-NP	CD	O	15	NMOD	0
15	kDa	kDa	I-NP	NN	O	11	PMOD	0
16	,	,	O	,	O	3	P	0
17	respectively	respectively	B-ADVP	RB	O	3	VMOD	0
18	.	.	O	.	O	2	P	0

1	MATERIALS	MATERIALS	B-NP	NNS	O	3	NMOD	0
2	AND	AND	I-NP	CC	O	3	NMOD	0
3	METHODS	METHODS	I-NP	NNS	O	6	SUB	0
4	:	:	O	:	O	6	P	0
5	U-995	U-995	B-NP	NN	B-cell_line	6	SUB	0
6	was	be	B-VP	VBD	O	0	ROOT	0
7	designed	design	I-VP	VBN	O	6	VC	0
8	to	to	B-VP	TO	O	9	VMOD	0
9	study	study	I-VP	VB	O	6	VMOD	0
10	human	human	B-NP	JJ	B-cell_type	14	NMOD	0
11	umbilical	umbilical	I-NP	JJ	I-cell_type	14	NMOD	0
12	vein	vein	I-NP	NN	I-cell_type	14	NMOD	0
13	endothelial	endothelial	I-NP	JJ	I-cell_type	14	NMOD	0
14	cell	cell	I-NP	NN	I-cell_type	20	NMOD	0
15	(	(	O	(	O	17	DEP	0
16	HUVEC	HUVEC	B-NP	NN	B-cell_line	17	DEP	0
17	)	)	O	)	O	14	NMOD	0
18	migration	migration	B-NP	NN	O	14	NMOD	14	migration
19	and	and	I-NP	CC	O	14	NMOD	0
20	proliferation	proliferation	I-NP	NN	O	9	OBJ	1	proliferation
21	in	in	B-ADVP	FW	O	24	NMOD	0
22	vitro	vitro	I-ADVP	FW	O	21	AMOD	0
23	and	and	O	CC	O	21	AMOD	0
24	angiogenesis	angiogenesis	B-NP	NN	O	9	VMOD	3	angiogenesis
25	induced	induce	B-VP	VBN	O	24	NMOD	17	induced
26	by	by	B-PP	IN	O	25	VMOD	0
27	TNF	TNF	B-NP	NN	B-protein	28	NMOD	0
28	alpha	alpha	I-NP	NN	I-protein	26	PMOD	0
29	in	in	B-PP	IN	O	25	VMOD	0
30	chicken	chicken	B-NP	NN	O	32	NMOD	0
31	chorioallantoic	chorioallantoic	I-NP	JJ	O	32	NMOD	0
32	membrane	membrane	I-NP	NN	O	29	PMOD	0
33	(	(	O	(	O	35	DEP	0
34	CAM	CAM	B-NP	NN	B-protein	35	DEP	0
35	)	)	O	)	O	32	NMOD	0
36	.	.	O	.	O	6	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	determined	determine	B-VP	VBD	O	0	ROOT	0
5	the	the	B-NP	DT	O	6	NMOD	0
6	ability	ability	I-NP	NN	O	4	OBJ	0
7	of	of	B-PP	IN	O	6	NMOD	0
8	U-995	U-995	B-NP	NN	B-cell_line	7	PMOD	0
9	to	to	B-PP	TO	O	6	NMOD	0
10	inhibiting	inhibit	B-VP	VBG	O	9	PMOD	18	inhibiting
11	tumor	tumor	B-NP	NN	O	13	NMOD	0
12	cell	cell	I-NP	NN	O	13	NMOD	0
13	growth	growth	I-NP	NN	O	15	NMOD	1	growth
14	and	and	O	CC	O	15	NMOD	0
15	metastasis	metastasis	B-NP	NN	O	10	OBJ	14	metastasis
16	.	.	O	.	O	4	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	U-995	U-995	B-NP	NN	O	11	SUB	0
4	(	(	O	(	O	9	DEP	0
5	15	15	B-NP	CD	O	7	AMOD	0
6	and	and	I-NP	CC	O	7	AMOD	0
7	30	30	I-NP	CD	O	8	NMOD	0
8	micrograms/ml	micrograms/ml	I-NP	NN	O	9	DEP	0
9	)	)	O	)	O	3	NMOD	0
10	markedly	markedly	B-ADVP	RB	O	11	VMOD	0
11	inhibited	inhibit	B-VP	VBD	O	19	VMOD	18	inhibited
12	HUVEC	HUVEC	B-NP	NN	B-cell_type	13	NMOD	0
13	migration	migration	I-NP	NN	O	19	SUB	14	migration
14	and	and	O	CC	O	19	VMOD	0
15	,	,	O	,	O	19	P	0
16	at	at	B-PP	IN	O	19	VMOD	0
17	15-50	15-50	B-NP	CD	O	18	NMOD	0
18	micrograms/ml	micrograms/ml	I-NP	NNS	O	16	PMOD	0
19	produced	produce	B-VP	VBD	O	1	NMOD	0
20	a	a	B-NP	DT	O	22	NMOD	0
21	dose-dependent	dose-dependent	I-NP	JJ	O	22	NMOD	0
22	decline	decline	I-NP	NN	O	19	OBJ	0
23	in	in	B-PP	IN	O	22	NMOD	0
24	[	[	B-NP	(	O	26	DEP	0
25	3H	3H	I-NP	NN	O	26	DEP	0
26	]	]	I-NP	)	O	28	NMOD	0
27	-thymidine	-thymidine	I-NP	JJ	O	28	NMOD	0
28	incorporation	incorporation	I-NP	NN	O	23	PMOD	0
29	.	.	O	.	O	1	P	0

1	30	30	B-NP	CD	O	3	AMOD	0
2	and	and	I-NP	CC	O	3	AMOD	0
3	50	50	I-NP	CD	O	4	NMOD	0
4	micrograms/ml	micrograms/ml	I-NP	NNS	O	0	ROOT	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	U-995	U-995	B-NP	NN	B-cell_line	5	PMOD	0
7	,	,	O	,	O	4	P	0
8	when	when	B-ADVP	WRB	O	4	VMOD	0
9	added	add	B-VP	VBN	O	8	SBAR	19	added
10	to	to	B-PP	TO	O	9	VMOD	0
11	TNF	TNF	B-NP	NN	B-protein	13	NMOD	0
12	alpha-induced	alpha-induced	I-NP	JJ	O	11	AMOD	17	induced
13	angiogenesis	angiogenesis	I-NP	NN	O	10	PMOD	3	angiogenesis
14	caused	cause	B-VP	VBD	O	8	SBAR	17	caused
15	discontinuous	discontinuous	B-NP	JJ	O	19	NMOD	0
16	and	and	I-NP	CC	O	19	NMOD	0
17	disrupted	disrupt	I-NP	VBN	O	19	NMOD	6	disrupted
18	blood	blood	I-NP	NN	O	19	NMOD	0
19	vessels	vessel	I-NP	NNS	O	14	OBJ	0
20	.	.	O	.	O	4	P	0

1	Moreover	Moreover	B-ADVP	RB	O	9	VMOD	0
2	,	,	O	,	O	9	P	0
3	U-995	U-995	B-NP	NN	B-cell_line	9	SUB	0
4	(	(	O	(	O	7	DEP	0
5	30	30	B-NP	CD	O	6	NMOD	0
6	micrograms/ml	micrograms/ml	I-NP	NNS	O	7	DEP	0
7	)	)	O	)	O	3	NMOD	0
8	markedly	markedly	B-ADVP	RB	O	9	VMOD	0
9	prevented	prevent	B-VP	VBD	O	0	ROOT	18	prevented
10	collagenase-induced	collagenase-induced	B-NP	JJ	O	11	NMOD	17	induced
11	collagenolysis	collagenolysis	I-NP	NN	O	9	OBJ	3	collagenolysis
12	.	.	O	.	O	9	P	0

1	In	In	B-PP	IN	O	0	ROOT	0
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	1	VMOD	0
4	when	when	B-ADVP	WRB	O	3	ROOT	0
5	200	200	B-NP	CD	O	6	AMOD	0
6	micrograms	microgram	I-NP	NNS	O	7	NMOD	0
7	U-995	U-995	I-NP	NN	B-cell_line	8	SUB	0
8	was	be	B-VP	VBD	O	4	SBAR	0
9	injected	inject	I-VP	VBN	O	8	VMOD	19	injected
10	i.p	i.p	B-ADJP	JJ	O	9	PRD	0
11	.	.	O	.	O	4	P	0

1	into	into	B-PP	IN	O	4	VMOD	0
2	mice	mouse	B-NP	NNS	O	1	PMOD	0
3	it	it	B-NP	PRP	O	4	SUB	0
4	suppressed	suppress	B-VP	VBD	O	0	ROOT	18	suppressed
5	sarcoma-180	sarcoma-180	B-NP	NN	O	7	NMOD	0
6	cell	cell	I-NP	NN	O	7	NMOD	0
7	growth	growth	I-NP	NN	O	13	NMOD	1	growth
8	and	and	O	CC	O	13	NMOD	0
9	B16-F10	B16-F10	B-NP	NN	O	13	NMOD	0
10	mouse	mouse	I-NP	NN	O	13	NMOD	0
11	melanoma	melanoma	I-NP	NN	O	13	NMOD	0
12	cell	cell	I-NP	NN	O	13	NMOD	0
13	metastasis	metastasis	I-NP	NN	O	4	OBJ	14	metastasis
14	in	in	B-ADVP	FW	O	4	VMOD	0
15	vivo	vivo	I-ADVP	FW	O	14	AMOD	0
16	.	.	O	.	O	4	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	These	These	B-NP	DT	O	4	NMOD	0
4	results	result	I-NP	NNS	O	5	SUB	0
5	suggest	suggest	B-VP	VBP	O	1	NMOD	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	anti-angiogenic	anti-angiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
9	effects	effect	I-NP	NNS	O	12	SUB	18	effects
10	of	of	B-PP	IN	O	9	NMOD	0
11	U-995	U-995	B-NP	NN	B-cell_line	10	PMOD	0
12	may	may	B-VP	MD	O	6	SBAR	0
13	be	be	I-VP	VB	O	12	VC	0
14	be	be	I-VP	VB	O	13	PRD	0
15	due	due	B-ADJP	JJ	O	14	PRD	17	due
16	to	to	B-PP	TO	O	15	AMOD	0
17	interference	interference	B-NP	NN	O	16	PMOD	18	interference
18	with	with	B-PP	IN	O	17	NMOD	0
19	the	the	B-NP	DT	O	22	NMOD	0
20	proliferation	proliferation	I-NP	NN	O	22	NMOD	1	proliferation
21	and	and	I-NP	CC	O	22	NMOD	0
22	migration	migration	I-NP	NN	O	18	PMOD	14	migration
23	of	of	B-PP	IN	O	22	NMOD	0
24	HUVECs	HUVEC	B-NP	NNS	B-cell_line	23	PMOD	0
25	as	as	B-CONJP	RB	O	28	NMOD	0
26	well	well	I-CONJP	RB	O	25	DEP	0
27	as	as	I-CONJP	IN	O	25	DEP	0
28	inhibition	inhibition	B-NP	NN	O	15	DEP	18	inhibition
29	of	of	B-PP	IN	O	28	NMOD	0
30	collagenolysis	collagenolysis	B-NP	NN	O	29	PMOD	0
31	,	,	O	,	O	15	P	0
32	thereby	thereby	B-VP	RB	O	33	VMOD	0
33	leading	lead	I-VP	VBG	O	15	AMOD	0
34	to	to	B-PP	TO	O	33	VMOD	0
35	inhibition	inhibition	B-NP	NN	O	34	PMOD	18	inhibition
36	of	of	B-PP	IN	O	35	NMOD	0
37	both	both	O	CC	O	42	NMOD	0
38	angiogenesis	angiogenesis	B-NP	NN	O	42	NMOD	3	angiogenesis
39	and	and	O	CC	O	42	NMOD	0
40	tumor	tumor	B-NP	NN	O	42	NMOD	0
41	cell	cell	I-NP	NN	O	42	NMOD	0
42	growth	growth	I-NP	NN	O	36	PMOD	1	growth
43	.	.	O	.	O	1	P	0

